$0.01
9.42%
Nasdaq, Mon, Dec 30 2024
ISIN
US39868T1051
Symbol
GRTS
Sector
Industry

Gritstone Oncology, Inc. Stock News

Neutral
Business Wire
3 months ago
EMERYVILLE, Calif.--(BUSINESS WIRE)--Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced it has filed a voluntary petition under chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. Gritstone intends to use the ...
Neutral
GlobeNewsWire
3 months ago
--Encouraging progression-free survival data in overall population; continued follow-up needed to allow data to mature further, especially in low ctDNA subgroup where events accrue more slowly
Neutral
GlobeNewsWire
5 months ago
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer (MSS-CRC); mature progression-free survival (PFS) data expected in the third quarter of 2024 -- -- Recent KOL event and patient advocacy engagements underscore the unmet need for new treatment options in...
Neutral
GlobeNewsWire
5 months ago
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Gritstone bio, Inc. (NASDAQ: GRTS) on behalf of long-term stockholders following a class action complaint that was filed against Gritstone on June 7, 2024 with a Class Period from March 9, 2023 to February 29, 2024. Our investiga...
Neutral
PRNewsWire
5 months ago
BENSALEM, Pa., Aug. 5, 2024 /PRNewswire/ -- Law Offices of Howard G.
Neutral
PRNewsWire
5 months ago
NEW YORK , Aug. 3, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. (NASDAQ: GRTS) between March 9, 2023 and February 29, 2024, both dates inclusive (the "Class Period"), of the important August 6, 2024 lead plaintiff deadline. So what: If you purchased Gritstone securities during the Class Period you may be ent...
Neutral
GlobeNewsWire
5 months ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Gritstone To Contact Him Directly To Discuss Their Options
Neutral
PRNewsWire
5 months ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Gritstone To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in Gritstone stock or options between March 9, 2023 and February 29, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh W...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today